“Bringing testing in-house, delivering #precisiononcology no matter where patients are treated.” Gabrielle Bertier and Melissa McConechy discuss the importance of applying technology for #equity in #cancercare on our latest coffee chat.
🎬 Watch here: https://t.co/Od521xSUwV
Such fun to chat with my great colleague Melissa about how the merger of @imagia_ai and @CanexiaHealth can bring us one step further in tackling #Cancer !
Equitable access to #cancercare— it’s the challenge we set out to tackle. In our latest Coffee Chat, Gabrielle & Melissa discuss the importance of in-house #biomarker testing in accomplishing this mission.
Learn more: https://t.co/HBtqSMPHtJ
#OnTheBlog#HealthEquity
Equitable access to #cancercare— it’s the challenge we set out to tackle. In our latest Coffee Chat, Gabrielle & Melissa discuss the importance of in-house #biomarker testing in accomplishing this mission.
Learn more: https://t.co/HBtqSMPHtJ
#OnTheBlog#HealthEquity
Apply your passion to a cancer-fighting mission!
We’re looking for a Chief Scientific Officer to lead our innovation portfolio, with the goal of leveraging #AI and #NGS-based genomics to accelerate #precisiononcology accessibility.
Details: https://t.co/ZpjzRFtTuF
“Imagia’s tech preserves #cancer healthcare #dataprivacy, while @CanexiaHealth’s solution tests, validates & delivers the analysis directly to the #oncologist.”
Check out the news of our #merger between two #oncology innovators, as featured on @BetaKit: https://t.co/DxKilXwSWG
SO excited about this new step ! Combining @imagia_ai’s AI expertise with @CanexiaHealth’s genomic testing solutions brings us one step further in the fight against cancer
Together, we can supercharge #PrecisionOncology. 🚀
Excited to announce this #merger to accelerate access to #genomics based #cancer treatment testing by combining @CanexiaHealth’s advanced molecular cancer solutions with @Imagia’s #AI expertise.
https://t.co/vR2RplHVd7
Modular, flexible, and #OpenSource. This is how we’ve designed our #AI Engine. Learn more about the engine optimized for #research discoveries on the latest #blog, authored by our technical team:
💡 https://t.co/xlIjHGl1Pg
For this month of #December, we are reflecting on 2021 and sharing some our highlights.
Today, our @dhdp_ Partnerships Manager, Gabrielle Bertier (@Gbertier), reflects on the year that got this groundbreaking initiative up and running.
#2021Highlights
Thrilled to share our new paper in collaboration with @FoundationATCG, assessing the impact of the biopsy site on TMB, an important #Immunotherapy biomarker, across 12 cancer types.
https://t.co/Z3ro9XinTA
For this month of December, we are reflecting on the year and sharing some our highlights.
To start us off, our Director of #Culture & #HR, Isabelle Paris, reflects on the incredible #resilience and camaraderie that Imagians showed through a challenging year.
#2021Highlights
We are pleased to welcome these four #AI institutes to the DHDP. Memberships strengthen our nationwide effort to mobilize Canada’s #KnowledgeEconomy and promote a ‘network effect’ to accelerate AI-driven #healthcare innovation.
👉 Full list of members: https://t.co/6d68z4oAHO
We are pleased to welcome these four #AI institutes to the DHDP. Memberships strengthen our nationwide effort to mobilize Canada’s #KnowledgeEconomy and promote a ‘network effect’ to accelerate AI-driven #healthcare innovation.
👉 Full list of members: https://t.co/6d68z4oAHO
25 Imagians participated in the #TerryFoxRun, with the spirit of hope and community on a beautiful #Montreal Sunday.
A great way to start off the week! 🌞
We are pleased to welcome these members to the DHDP. Memberships strengthen our nationwide effort to mobilize Canada’s knowledge economy and promote a ‘network effect’ to accelerate AI-driven healthcare innovation.
#CanadianInnovation
Be a part of the #innovation - join our team! Contribute to the adoption of #PrecisionMedicine for cancer in Canada.
Open positions 👉
Strategy: https://t.co/eUv1SDRLc3
Data Governance: https://t.co/8EipuggyBH
#Hiring#Careers
🔬Therapeutic solutions that specifically respond to #patient needs while integrating #incentives, from both the public and the private sector.
This is what excites Nadine Beauger, CEO of @IRICoR_, about being part of the DHDP.
🤝 https://t.co/RTwA2RTqHK
We are excited to announce that our study testing the potential of #DeepRadiomics methods in predicting #immunotherapy response, an abstract published in collaboration with Dr. Bertrand Routy’s lab at the @CRCHUM; will be presented at #ESMO2021.
👉 https://t.co/3XvDJEpUEw
🇨🇦 The possibility of moving #Canada into the forefront of #CancerResearch.
This is what excites Dr. Laszlo Radvanyi, President of @OICR_news, about being part of the DHDP.
🤝 Get to know our Executive Committee members: https://t.co/RTwA2RTqHK
La DHDP a été fondée avec la vision d'apporter la puissance de l'écosystème canadien pour accélérer les percées médicales novatrices axées sur l'#IA.
Nous sommes impatients de faire de cette vision une réalité avec le Dr Jim Woodgett.
En savoir plus: https://t.co/fF4IPel1kW